1.H. Zhang, S. Huang, X. Zou, W. Shi, M. Liang, Y. Lin, M. Zheng,X. Tang*. Exploring biosynthetic potential ofTistrellaspecies for producing didemnin antitumor agents.ACS Chemical Biology, 2024, 19, 10, 2176–2185

2.Z. Cheng, B.B. He, K. Lei, Y. Gao, Y. Shi, Z. Zhong, H. Liu, R. Liu, H. Zhang, S. Wu, W. Zhang*,X. Tang*, Y. X. Li*. Rule-based omics mining reveals antimicrobial macrocyclic peptides against drug-resistant clinical isolates.Nature Communications, 2024, 15(1), 4901

3.X. Wang, N. Chen, P. Cruz-Morales, B. Zhong, Y. Zhang, J. Wang, Y. Xiao, X. Fu, Y. Lin, S. Acharya, Z. Li, H. Deng, Y. Sun, L. Bai,X. Tang*, J.D. Keasling*, X. Luo*. Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis.Nature Metabolism,2024, 6, 933–946

4.H. Zhang, X. Li, S. Huang, M. Cai, W. Shi, M. Liang, Y. Lin, J. Shen, M. Sui, Q. Lai, J. Dou, Z. Shao, X. Luo, Y. Ge*,X. Tang*. A semisynthesis platform for efficient production and exploration of didemnin-based drugs.Angew. Chem. Int. Ed., 2024, 63(12), e202318784

5.X. Zou, Z. Hui, R.A. Shepherd, S. Zhao, Y. Wu, Z. Shen, C. Pang, S. Zhou, Z. Yu, J. Zhou, B.S. Moore, L.M. Sanchez,X. Tang*. Unveiling a CAAX protease-like protein involved in didemnin drug maturation and secretion.Advanced Science, 2024, 11(4), e2306044